GENEX

GENEX by Bausch+Ströbel is a groundbreaking robotic platform for aseptic fill-finish operations, engineered to meet the next generation of pharmaceutical production needs—especially in biologics and advanced therapy medicinal products (ATMPs). Unlike conventional systems, GENEX replaces manual interventions with fully robotic automation across all critical steps: container handling, filling, stoppering, sealing, and even environmental- and surface monitoring. These operations occur in a compact, Grade A closed isolator—ensuring the highest level of sterility without glove ports or operator intrusion.

GENEX is also modular and easy scaleable, allowing pharmaceutical manufacturers to reconfigure or expand their system quickly, adapting to new products or formats without extended downtime or revalidation. With robotic changeovers, batch switching can be completed in minutes, making GENEX ideal for multi-product facilities or short-run manufacturing.

A unique feature of GENEX is its matrix production possibility. Each unit functions as an autonomous, intelligent node that can be networked in parallel or distributed production environments. This makes GENEX a foundational technology for future-ready pharmaceutical manufacturing strategies, including decentralized production or pandemic response systems.

GENEX isn’t just a new machine—it’s a revolutionary aseptic fill and finish production equipment that combines robotics, modularity, and utmost sterility assurance to meet the rapidly changing demands of modern drug development and delivery.